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Abstract. A combination of Southern blot analysis on a carcinoma DNAs. The breakpoints in these tumors are not the
panel of tumor-derived somatic cell hybrids and fluorescence in same, but map within a region of approximately 6.5 kb.
situ hybridization techniques was used to map YACs, cosmids Through preparative gel electrophoresis an (X;l) chimaeric
and DNA markers from the Xpl 1.2 region relative to the X 4.4-kb EcoRl fragment could be isolated which encompasses
chromosome breakpoint of the renal cell carcinoma-associated the breakpoint region present on der(X). Preliminary charac-
t(X;l)(pl l;q21). The position of the breakpoint could be deter- terization of this fragment revealed the presence of a 150-bp
region with a strong homology to the 5' end of the mouse TFE3mined as follows: Xcen-OATL2-DXS146~DXS255-SYP-
t(X;l)-TFE3-OATLl~Xpter. Fluorescence in situ hybridiza- cDNA in the X-chromosome part, and a 48-bp segment in the
tion experiments using TFE3-containing YACs and cosmids chromosome 1-derived part identical to the 5' end of a known
revealed split signals indicating that the corresponding DNA EST (accession number R93849). These observations suggest
inserts span the breakpoint region. Subsequent Southern blot that a fusion gene is formed between the two corresponding
analysis showed that a 2.3-kb ü-VoRI fragment which is present genes in t (X; 1 )(p 11 ;q21)-positive papillary renal cell car- 
in all TFE3 cosmids identified, hybridizes to aberrant restric­
tion fragments in three independent t(X; 1 ^-positive renal cell
"S.
M «
Renal cell carcinomas (RCCs) form a very heterogeneous (Dal Cin et al., 1992; Elfving et al., 1995; van den Berg et al., 
group of tumors, both on a histologic and a cytogenetic level.
These tumors can be subdivided into clear cell type nonpapilla- In addition, a t(X;l)(pll;q21) and variants thereof have
ry and chromophilic tumors with a papillary growth pattern, repeatedly been described in a subset of papillary renal cell car-
commonly referred to as papillary tumors. Whereas in nonpa- cinomas (de Jong et al., 1986; Tomlinson et al., 1991; Meloni et
pillary carcinomas abnormalities involving the short arm of al., 1993; Tonk et al., 1995; Dijkhuizen et al., 1995; Zhao et al.,
chromosome 3 prevail, these appear to be absent in papillary Marti Despite the limi
carcinomas. In contrast, recurrent numerical aberrations in- amount of data on the histologic details of these tumors, there is 
volving mainly chromosomes 7,17 and the Y chromosome are growing evidence that this translocation is specific for a subset 
detected (Kovacs et al., 1991; van den Berg et al., 1993), of papillary RCCs, i.e. those chromophilic tumors showing 
although some of these alterations may not be tumor-specific, some clear cell-like features, due to the deposition of fat and 
since they also occur in the surrounding normal kidney tissue glycogen (Thoenes et al., 1986; Meloni et al., 1993; Tonk et al.,
1995; Dijkhuizen et al., 1995). Since this translocation is some­
times the sole cytogenetic anomaly present (de Jong et al., 
1986), the gene(s) involved in this translocation may play a cru­
cial role in tumor development. Therefore, we set out to clone 
the t(X;l) via detailed mapping of the breakpoint within Xpl 1 
and the subsequent isolation and characterization of a chimaer­
ic genomic fragment.
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Materials and methods
Tumor cell lines and somatic cell hybrids
Two primary renal ccll cultures (C189-12117 and C189-17872) and one 
primary tumor (REN11-TT) (Tonk ct at, 1995), all male-derived, were used 
in this study. C189-12117 contains the t(X;l) as the only abnormality, where­
as C189-17872 also shows numerical aberrations in addition to the t(X;l) 
(Meloni et al., 1993). The karyotype of REN 11-TT reads as follows: 
49,'Y ,t(X; 1 )(p 11 ;q21 ),+der(X)t(X; 1 )(p 11 ;q21 ),+5 -16,+17,+18. REN 11 -N 
represents the corresponding normal tissue. C189-12117-derived somatic cell 
hybrids were obtained as described before (Gcurts van Kessel ct al., 1983; 
Sinke et al., 1993). Briefly, after fusion of A3 or Wg3h hamster cell lines and 
the t(X;l)-positive 0189-12117 renal carcinoma cells, a panel of somatic cell 
hybrids was isolated in which the reciprocal translocation chromosomes 
segregate. WgRe5 was chosen as the der(X) hybrid, A3Re3A as the dcr( 1) 
hybrid (Sinke et al., 1993). As controls, two hybrid lines containing a normal 
X chromosome (578, Wieaeker et al., 1984) or a normal chromosome 1 
( G M 13.139, Coriel] Repository) as the only human constituent, and parental 
hamster (A3) and mouse (A9) cell lines were included. 111,60 is a myeloid 
leukemia cell line. G 1 is a Grawitz tumor from an unrelated patient, N K 1 the 
corresponding normal tissue, and NK2 normal renal tissue from another 
unrelated patient with renal cancer.
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Fig. 1. Schematic map of the papillary RCC-associated t(X;l) region 
within Xp l l. The position of the breakpoint is indicated by an arrow.
DNA probes and Southern blot analysis
Probes were labeled by random priming and hybridized at 650 C in 0.5 M 
sodium phosphate buffer, 1 mM EDTA, and 7% SDS. Due to the presence of 
repetitive sequences, 14E6 and 4.4-kb probes were prcannealed for 3-5 h at 
650 C in 0.12 M sodium phosphate buffer in the presence of 100-250 j:tg total 
human DNA or hybridime (HT Biotechnology). Washes were performed in
Sequence and computer analysis
DNA sequences were analyzed on an automated DNA sequencer (ABI 
373A) using the Taq Dye Deoxy Terminator Cycle Sequencing kit (Applied
40 mM sodium phosphate, 0.1 % SDS. Hybridizations of the library filters Biosystems). Searches for homology were performed using the FASTA pro- 
were performed in the same manner. Washes were performed stepwise, start- grams, 
ing with 100 mM phosphate, 0.5 % SDS, 1 mM EDTA which was decreased 
to 40 mM, 0.1% SDS.
Genomic DNA was isolated using standard protocols by proteinase K,
SDS treatment followed by phenol, chloroform extractions and ethanol pre­
cipitation. After digestion and size selection on an agarose gel, the DNA was 
blotted onto Ilybond N-Plus (Amersham) or Genescreen Plus (Dupont) 
membranes.
Results and discussion
Mapping of lhe X-chromosome bn 
Based on previous studies by us i
buijk et al., 1993; Sinke et al., 1993;
et al., 1995), the papillary 
(p 11.2;q21 ) breakpoint on the X chr
ir groups (Sunker-
et alM 1995;
t(X; 1 ) 
i was mapped in a
YAC and eosnrid probes were labeled with digoxigenin-l1-dlJTP (Boeh- 
ringer Mannheim), and centromere probes (X-speeific alphoid sequence 
probe pBamX5) with Cy3-dCTP (BDS/KIMTEC) using a nick translation kit
(Life Technologies). After coprecipitation with a 50-fold excess of Cot-1 clusters OATL1 and OATL2. Initial FISH experiments showed
a split signal in t(X;l)-positive tumor cells when using an 
OATL2 YAC as a probe (Suijkerbuijk et al., 1993). However, 
we found that this observation resulted from the presence of
(low-
DNA and heating for 10 min at 80 °C, repetitive sequences present in the 
YACs were preannealed for 30 min at 37 °C in 7 j.il of FDST (50% deionized 
formamide, 10% d ext ran sulphate, 2 x SSC, 1 % [v/v] Tween-20, pll 7.0).
Chromosome slides were treated as described before (Dijkhuizen et al.,
1995). After hybridization (50% formamide, 2 * SSC) which was performed 
at 37 °C for at least 48 h, and washes (50% formamide, 2 x SSC; 2 x SSC), 
immunochemical detection was carried out using HTC-eonjugated shecp- 
antidigoxigenin (1:20; Doehringer Mannheim). The slides were mounted in 
anti-fade medium (1.4% w/v dia/.obieyelo-(2,2,2)-oetane (DABC’O, Merck) 
containing DAPI (0.5 ng/ml, Sigma) for counterstaining of the chromosomes.
Slides were analyzed under a Zeiss Axiophot epifluoreseenee microscope Xpl 1 breakpoint. pTAK8/DXS14(> and M27[VDXS255-posi-
et al., v  y  W
ern
s of the breakpoint 
et al., 1995). By using South-
o f lu mor­ somi
hybrids and FISH on t(X; 1 )-positive tumor cells, we have map­
ped additional YACs from this genomic region relative to the
equipped with appropriate filters. Digital images were captured as described 
before (Dijkhuizen et al. 1995) using the processing software program BDS- 
image
Construction o f the genomic slice librari
tive YACs (Fig. 1) mapped to der(X), as well as YACs from a 
con tig extending approximately 1 Mb telomeric to M27ß (Fish­
er et al., 1995). Three different SYP-containing cosmids (SYP 
A, G, and H), all mapped to der(X) as determined by both
100 ng of genomic DNA from the CI89-12117 tumor cells was digested, FISH and Southern blot analysis. This observation was con-
divided over 10 slots, and run on a I % agarose gel. A vertical slice corre­
sponding to one lane was blotted onto Hybond N-plus Membrane (Amers­
ham, UK) and screened for the location of the breakpoint fragment. Three 
slices of 1.5, 2.5, and 1.5 mm were cut out of the gel, and the DNA was 
subsequently purified using standard methods. About 200 ng of this DNA mapped to der(l) (Fig. 2B), indicating that 
was rerun on a gel and checked for the presence of the breakpoint fragment
firmed by the hybridization of a 7-kb genomic SYP fragment to 
der(X) as shown in Fig. 2A. In contrast, a 1.9-kb TFE3 cDNA 
clone that we isolated, designated cp 13
via Southern blot hybridizations. The DNA fragments were cloned in a lamb- 
da-ZAP vector (Stratagene) and packaged using Gigapaek Gold packaging 
extract (Stratagene).
breakpoint must be located between the latter two markers
(Fig. 1). F data TFE3 YACs (TFE3/2; 100 kb and
TFE3/3; kb; Fisher et al.,
mainly mapped to der(X), whereas TFE3/3 appeared to give a
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Fig. 3. Southern blot analysis using 14E6 as a probe showing aberrantly 
hybridizing bands in three t(X;l)-positive tumor DNAs. A3 and A9 are the
parental rodent controls, “X ” and “ I ”
Fig. 2. Southern blot analysis of somatic cell hybrids using SYP (A) or somes as the only human component, “dX” and “d I
«
U 1 »controls, “X ” and “ 1 
human component, and “d” and “dl
cpl3/TFE3 (B) as probes. “A3” and “mouse” are the hamster and mouse ing the der(X) and der (1), respectively, RCC'l and RCC2 the Cl89-12117
and C189-17872 renal cancer cells containing the t(X;l), REN11-TT the 
third (X; 1 )-positive RCC, REN11-N normal kidney tissue from the same 
patient, G1 Grawitz tumor 1, NK normal kidney tissue, isolated from a
and
t(X; 1). The myeloid leukemia cell line HL60 was used for a total human patient with renal cancer, and HL60 a myeloid leukemia cell line. Genomic 
DNA control. Lambda /////dill DNA was used as a molecular size marker. digests were (A) £twRI, (B) lig ill. Lambda ///mill! was used as a molecular
size marker.The restriction enzymes used were: Ec
split signal. However, t 
significantly above background level, 
nary results, an
not rise
on
were isolated.
probes resulted in a pattern similar 
i.e. some cosmids showed a split signal, i
YACs and cosmids may indeed span the 
region.
ern
, an a ber-
♦ f-
' 1 I g\ present in this
breakpoints in
these three cases differ slightly, but all map within a genomic
a t m a x i m u m.
using Ec
tive tumors (C189-12117, Cl 89-17872, REN11-TT) as well as the position of the 4.4-kb band. Three horizontal slices sur-
C112117-derived somatic cell hybrids and controls. A 2.3-kb were cut out,
the DNA. A small amount was rerun on a gel, and
EcoRl bands of 4.4 and 4.5 kb in the C l89-12117 and C189- 
17872 tumor cells, respectively, (Fig. 3A). The corresponding
der(X) containing somatic cell hybrid. In tumor REN 11-TT no approximately 10ft ree
severi After in
this probe.
I *
s were
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cagGAGAGGC GTGAGCGTCG GGAACAGGCC 
GCCGCGGCTC CCTTCCCCAG TCCTGCACCT 
GCCTCTCCTG CCATCTCTGT GGTTGGCGTC 
TCTGCTGGGG GCCACACATT GAGCCGTCCA 
CCCCCTGCTC AGGTGCCCAG GGAGGTGCTC 
AAG gtaag
1 t t c t t t t t c t  cttagTCAG A TTCTGAGGAA 
31 GATGAACCCA CAAAGAAGAA AACTATGCTT 
61 CAGgtaag
Fig. 5. Southern blot analysis on a panel of somatic cell hybrids and con­
trols using the 4.4-kb breakpoint fragment as a probe. A3 and A9 are the 
parental rodent controls, “X ” and “ 1” the hybrids containing these chromo­
somes as the only human component, udX” and “d I ” the hybrids containing 
the der(X) and der (1), respectively, RCC1 and RCC2 the 089-12117 and 
C'189-17872 renal cancer cells containing the t(X;l), REN11-TT the third spending part in the 5' end of EST yt72et)4 (R93849). Suspected e\*nt 
(X; 1 )-positive RCC. The aberrant (4.4 and 4.5 kb) and normal bands (2.3 kb; sequences based on consensus exon and intron boundaries and the honiolit£> 
10-12 kb) are indicated by arrows. Lambda ///«dill DNA was used as a to the mouseTFE3 cDNA, are shown in capital letters. K: AVfjRI. I»: /s#t, H 
molecular si/e marker. The DNA was digested with /i’coRL
Fig. 6. Schematic map of the 4.4-kb breakpoint fragment. The breakpoint 
is indicated by an arrow, the positions of coding sequences I and II arc ind i­
cated by boxes. Sequence I shows 87 % identity to the first 150 nucleotide1» ui 
the mouse TFE3cDNA (S76673). Sequence II is 100% ident ical un ite  c u m
of human TFE3. The position of this fragment relative to the
fragment, a 48-bp. sequence was detected which appeared to be 
identical to the 5'-part of a known EST (accession number 
R93849). These preliminary data suggest that a fusion gene is 
formed between the transcription factor TFE3 on chromosome 
X, and a novel gene on chromosome 1 designated PRCC (papil­
lary renal cell carcinoma, translocation-associated). Currently, 
we are characterizing the full length normal and fusion cDNAs 
representing the genes involved in t(X;l)(pl l;q21).
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